查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040866

心臟病學領域人工智慧市場規模、佔有率和趨勢分析報告：按組件、應用、疾病、地區和細分市場分類（2026-2033 年）

AI In Cardiology Market Size, Share & Trends Analysis Report By Component (Software, Hardware, Services), By Application (Diagnosis, Prediction, Drug Discovery), By Medical Condition, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

心臟病學人工智慧市場概述

2025年全球心臟病學人工智慧市場規模估計為16.9億美元，預計到2033年將達到148.3億美元。

從2026年到2033年，該領域預計將以31.17%的複合年成長率成長。心血管疾病在全球的盛行率不斷上升，加上心臟科醫師越來越重視提高診斷準確性以及心臟影像影像技術的快速發展，是推動人工智慧（AI）在心臟病學領域應用日益廣泛的主要因素。

例如，2026年1月，Clearly公司宣布安泰保險公司擴大了其AI-QCT斑塊分析技術的保險覆蓋範圍。這將有助於透過先進的AI冠狀動脈影像技術來改善冠狀動脈疾病的診斷和風險評估，並擴大該技術在所有投保族群中的臨床應用。

心血管疾病（CVD）盛行率增加

推動人工智慧（AI）在心臟病學領域發展的主要動力是心血管疾病（CVD）盛行率的不斷上升，以及由此產生的高效醫療保健解決方案日益成長的需求。根據世界衛生組織（WHO）統計，心血管疾病仍是全球主要死因之一。例如，預計2022年將有1,980萬人死於心血管疾病，約佔全球死亡總數的32%。同樣，根據美國疾病管制與預防中心（CDC）的數據，2023年美國將有9,19,032人死於心血管疾病，佔全球死亡總數的三分之一。日益沉重的疾病負擔使得開發和應用先進技術以改善疾病管理和患者預後變得至關重要。

高血壓、冠狀動脈疾病、心臟衰竭和心律不整等疾病的高發給全球醫療保健系統帶來了沉重負擔。傳統的診斷和治療方法往往耗時費力，且可能缺乏實現最佳患者照護所需的精準度。人工智慧透過提高心血管疾病檢測、診斷和管理的準確性和效率，提供了變革性的解決方案。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：心臟病學領域的人工智慧市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 個案研究的啟示
  • 心臟病學領域的人工智慧市場分析工具

第4章：心臟病學領域的人工智慧市場：按組件分類的估算和趨勢分析

  • 全球心臟病學領域人工智慧市場：基於組件的波動分析
  • 全球心臟病學人工智慧市場：基於組件的規模和趨勢分析，2021-2033年
  • 軟體
  • 硬體
  • 服務

第5章：心臟病學領域的人工智慧市場：基於應用的估算和趨勢分析

  • 全球心臟病學人工智慧市場：基於應用的波動分析
  • 全球心臟病學人工智慧市場：基於應用的規模和趨勢分析（2021-2033年）
  • 診斷
  • 預言
  • 藥物發現
  • 其他

第6章：心臟病學領域的人工智慧市場：疾病評估與趨勢分析

  • 全球心臟病學人工智慧市場：疾病波動分析
  • 疾病特異性分析：2021年至2033年全球心臟病學人工智慧市場規模及趨勢
  • 心律不整
  • 心臟衰竭
  • 缺血性心臟疾病
  • 其他

第7章：心臟病學領域的人工智慧市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 2025年公司市場分析
  • 公司簡介列表
    • GE Healthcare
    • Heartflow, Inc.
    • IDOVEN
    • CardiAI
    • Ultromics Limited
    • Arterys Inc.（Tempus AI）
    • Ultrasight
    • Koninklijke Philips NV
    • Vista AI
    • Viz.ai, Inc.
    • RSIP Vision
    • Cleerly, Inc.
    • Medical AI Co., Ltd.
    • Anumana, Inc.
    • Aidoc
    • Circle Cardiovascular Imaging Inc.
    • Eko Health, Inc.
    • cardiomatics.com
Product Code: GVR-4-68040-047-1

AI In Cardiology Market Summary

The global AI in cardiology market size was estimated at USD 1.69 billion in 2025 and is projected to reach USD 14.83 billion by 2033, growing at a CAGR of 31.17% from 2026 to 2033. The rising global prevalence of cardiovascular diseases, coupled with the increasing focus of cardiac specialists on enhancing diagnostic precision and rapid advancements in cardiac imaging technology, are among the key factors responsible for expanding the applications of artificial intelligence (AI) in cardiology.

For instance, in January 2026, Cleerly, Inc. announced that Aetna expanded coverage for its AI-QCT plaque analysis technology, supporting improved diagnosis and risk assessment of coronary artery disease through advanced AI-enabled coronary imaging and broader clinical adoption across the insured population.

Increasing prevalence of cardiovascular diseases (CVDs)

A primary factor driving the growth of artificial intelligence (AI) in cardiology industry is the increasing prevalence of cardiovascular diseases (CVDs) and the consequent need for efficient & effective healthcare solutions. According to the WHO, CVD remains the leading cause of mortality worldwide. For instance, an estimated 19.8 million people died from CVDs in 2022, representing approximately 32% of all global deaths. Similarly, according to the Centers for Disease Control and Prevention (CDC), 919,032 people died from cardiovascular disease in the U.S. in 2023, equivalent to one in every three deaths. This escalating burden necessitates the development and implementation of advanced technologies to improve disease management and patient outcomes.

The high prevalence of conditions such as hypertension, coronary artery disease, heart failure, and arrhythmia puts a substantial strain on healthcare systems globally. Traditional diagnostic & treatment methods are often time-consuming & resource-intensive and are likely to lack the precision required for optimal patient care. AI offers a transformative solution by enhancing the accuracy and efficiency of CVD detection, diagnosis, and management.

Global AI In Cardiology Market Report Segmentation

This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global AI in cardiology market report based on component, application, medical condition, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Hardware
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnosis
  • Prediction
  • Drug Discovery
  • Others
  • Medical Condition Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiac Arrhythmias
  • Heart Failure
  • Ischemic Heart Disease /CAD
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Application Segment
    • 1.2.3. Medical Condition Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Artificial Intelligence in Cardiology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing burden of cardiovascular diseases and the need for efficient healthcare solutions
      • 3.2.1.2. Increasing strategic initiatives by industry players
      • 3.2.1.3. Rapid technological advancements and growing adoption of remote patient monitoring solutions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Highly regulated industry
      • 3.2.2.2. High implementation and procurement costs
      • 3.2.2.3. Shortage of healthcare personnel in information technology
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Case Study Insights
  • 3.4. Artificial Intelligence in Cardiology Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape
      • 3.4.2.6. Social Landscape

Chapter 4. Artificial Intelligence in Cardiology Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Artificial Intelligence in Cardiology Market Component Movement Analysis
  • 4.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Artificial Intelligence in Cardiology Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Artificial Intelligence in Cardiology Market Application Movement Analysis
  • 5.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Diagnosis
    • 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Prediction
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Drug Discovery
    • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Artificial Intelligence in Cardiology Market: Medical Condition Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Artificial Intelligence in Cardiology Market Medical Condition Movement Analysis
  • 6.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Medical Condition, 2021 to 2033 (USD Million)
  • 6.4. Cardiac Arrhythmias
    • 6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Heart Failure
    • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Ischemic Heart Disease /CAD
    • 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Artificial Intelligence in Cardiology Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. GE Healthcare
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Technology type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Heartflow, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Technology type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. IDOVEN
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Technology type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. CardiAI
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Technology type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Ultromics Limited
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Technology type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Arterys Inc. (Tempus AI)
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Technology type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Ultrasight
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Technology type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Koninklijke Philips N.V.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Technology type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Vista AI
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Technology type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Viz.ai, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Technology type benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. RSIP Vision
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Technology type benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Cleerly, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Technology type benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Medical AI Co., Ltd.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Technology type benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Anumana, Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Technology type benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Aidoc
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Technology type benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Circle Cardiovascular Imaging Inc.
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Technology type benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Eko Health, Inc.
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Technology type benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. cardiomatics.com
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Technology type benchmarking
      • 8.4.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 4 North America AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 6 U.S. AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 7 U.S. AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 9 Canada AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 10 Canada AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 12 Mexico AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 13 Mexico AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 15 Europe AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 17 Europe AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 18 Europe AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 19 Germany AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 20 Germany AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 22 UK AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 23 UK AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 25 France AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 26 France AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 27 France AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 28 Italy AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 29 Italy AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 30 Italy AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 31 Spain AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 32 Spain AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 33 Spain AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 34 Denmark AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 35 Denmark AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 36 Denmark AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 37 Sweden AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 38 Sweden AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 40 Norway AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 41 Norway AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 42 Norway AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 43 North America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 48 China AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 49 China AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 50 China AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 51 Japan AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 52 Japan AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 53 Japan AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 54 India AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 55 India AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 56 India AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 57 South Korea AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 58 South Korea AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 59 South Korea AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 60 Australia AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 61 Australia AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 62 Australia AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 63 Thailand AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 64 Thailand AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 65 Thailand AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 66 Latin America AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 67 Latin America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 68 Latin America AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 69 Latin America AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 70 Brazil AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 71 Brazil AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 72 Brazil AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 73 Argentina AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 74 Argentina AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 75 Argentina AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 76 MEA AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 77 MEA AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 78 MEA AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 79 MEA AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 80 South Africa AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 81 South Africa AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 82 South Africa AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 86 UAE AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 87 UAE AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 88 UAE AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 89 Kuwait AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 90 Kuwait AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 91 Kuwait AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 4 North America AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 6 U.S. AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 7 U.S. AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 9 Canada AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 10 Canada AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 12 Mexico AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 13 Mexico AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 15 Europe AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 17 Europe AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 18 Europe AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 19 Germany AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 20 Germany AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 22 UK AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 23 UK AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 25 France AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 26 France AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 27 France AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 28 Italy AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 29 Italy AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 30 Italy AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 31 Spain AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 32 Spain AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 33 Spain AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 34 Denmark AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 35 Denmark AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 36 Denmark AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 37 Sweden AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 38 Sweden AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 40 Norway AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 41 Norway AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 42 Norway AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 43 North America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 48 China AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 49 China AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 50 China AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 51 Japan AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 52 Japan AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 53 Japan AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 54 India AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 55 India AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 56 India AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 57 South Korea AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 58 South Korea AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 59 South Korea AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 60 Australia AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 61 Australia AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 62 Australia AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 63 Thailand AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 64 Thailand AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 65 Thailand AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 66 Latin America AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 67 Latin America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 68 Latin America AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 69 Latin America AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 70 Brazil AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 71 Brazil AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 72 Brazil AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 73 Argentina AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 74 Argentina AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 75 Argentina AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 76 MEA AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 77 MEA AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 78 MEA AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 79 MEA AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 80 South Africa AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 81 South Africa AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 82 South Africa AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 86 UAE AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 87 UAE AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 88 UAE AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 89 Kuwait AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 90 Kuwait AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 91 Kuwait AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Artificial intelligence in cardiology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 AI in Cardiology Market snapshot
  • Fig. 7 AI in Cardiology Market segment snapshot (Part 1)
  • Fig. 8 AI in Cardiology Market segment snapshot (Part 2)
  • Fig. 9 AI in Cardiology Market competitive landscape snapshot
  • Fig. 10 Market research process
  • Fig. 11 Parent market outlook (USD Billion) (2025)
  • Fig. 12 AI in cardiology market dynamics
  • Fig. 13 Few notable funding in AI in cardiology market
  • Fig. 14 Comparison between AI-integrated healthcare and traditional healthcare
  • Fig. 15 AI in cardiology market: Porter's five forces analysis
  • Fig. 16 AI in cardiology market: PESTLE analysis
  • Fig. 17 Artificial intelligence in cardiology market, component outlook key takeaways (USD Million)
  • Fig. 18 Artificial intelligence in cardiology market: Component movement analysis, 2025 & 2033 (USD Million)
  • Fig. 19 Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Artificial intelligence in cardiology market, application outlook key takeaways (USD Million)
  • Fig. 23 Artificial intelligence in cardiology market: Application movement analysis, 2025 & 2033 (USD Million)
  • Fig. 24 Diagnosis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Prediction market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Artificial intelligence in cardiology market, medical condition outlook key takeaways (USD Million)
  • Fig. 29 Artificial intelligence in cardiology market: Medical condition movement analysis, 2025 & 2033 (USD Million)
  • Fig. 30 Cardiac arrhythmias market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Heart failure market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 ischemic heart disease/CAD market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 AI in Cardiology Market: Regional outlook
  • Fig. 36 North America artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 U.S artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Canada artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Mexico artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 43 Europe artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 UK artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Germany artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 France artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Italy artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Spain artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Denmark artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Japan artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 China artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 India artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Australia artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Thailand artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 South Korea artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 73 Latin America artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Brazil artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Argentina artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
  • Fig. 78 MEA artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Africa artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Saudi Arabia artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 UAE artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Kuwait artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 87 Company Categorization
  • Fig. 88 Company market position/share analysis, 2025
  • Fig. 89 Strategic Framework